🇺🇸 FDA
Pipeline program

Invivo CAR-T

PBC027-1

Phase 1 mab active

Quick answer

Invivo CAR-T for B-Acute Lymphoblastic Leukemia is a Phase 1 program (mab) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).

Program details

Company
PRECISION BIOSCIENCES INC
Indication
B-Acute Lymphoblastic Leukemia
Phase
Phase 1
Modality
mab
Status
active

Clinical trials